S
SABS//CIK 0001833214
SAB Biotherapeutics, Inc.
Market Data
$3.72−$0.13 (−3.38%)
SABS · Last trade
Prev Close
$3.85
Range (30d)
$3.62 – $3.93
Recent Filings
- SCHEDULE 13G/A11.0 KBSAB Biotherapeutics, Inc.Aug 14, 5:20 PM ET·0001193125-26-352646
- SCHEDULE 13G/A10.1 KBSAB Biotherapeutics, Inc.Aug 14, 4:52 PM ET·0001727492-26-000022
- SCHEDULE 13G/A16.1 KBSAB Biotherapeutics, Inc.Aug 14, 4:07 PM ET·0001831942-26-000035
- SCHEDULE 13G/A20.6 KBSAB Biotherapeutics, Inc.Aug 14, 4:07 PM ET·0001213900-26-090054
- SCHEDULE 13G/A10.0 KBSAB Biotherapeutics, Inc.Aug 14, 11:04 AM ET·0000919574-26-005263
- SCHEDULE 13G/A15.9 KBSAB Biotherapeutics, Inc.Aug 14, 6:08 AM ET·0001172661-26-003437
- SCHEDULE 13G15.8 KBSAB Biotherapeutics, Inc.Aug 12, 12:08 PM ET·0000919574-26-004984
- SCHEDULE 13D/A17.0 KBSAB Biotherapeutics, Inc.Aug 10, 4:27 PM ET·0001346824-26-000220
- 10-Q15.2 MBSAB Biotherapeutics, Inc.Aug 6, 7:56 AM ET·0001193125-26-336783
- 8-K273.2 KBSAB Biotherapeutics, Inc.Jul 7, 8:15 AM ET·0001193125-26-296936
Insiders
10- Bausch Christoph LawrenceCHIEF OPERATING OFFICER
- Beyer Russell PChief Financial Officer
- Big Cypress Holdings LLCDirector, CEO and CFO, 10% Owner
- Carillo Carlos NSVP Regulatory Affairs
- Collins Stephen D.Director
- Conley Mark WilliamSee Remarks
- Ellias Helen K.Director
- Erickson Bruce KippChief Operating Officer
- Finnegan FrederickChief Business Officer
- Giberson ScottDirector
Tickers
Addresses
business
777 W 41ST ST SUITE 401
MIAMI BEACH, FL, 33140
mailing
777 W 41ST ST SUITE 401
MIAMI BEACH, FL, 33140
Former Names
- Big Cypress Acquisition Corp.2021-10-22